| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 2.5K | 1.9% |
| Total Income | 2.5K | 1.9% |
| Expenditure | 2.1K | 0.9% |
| PBT | 377.70 | 21.4% |
| Net Profit | 319.50 | 32.9% |
| OPM | — | |
| NPM | 12.89% | 3.00pp |
| EPS | 2.17 | 31.5% |
BIOGEN INC. - Earnings Press Release Analysis
06 Apr 2026 · 6 Apr, 4:01 pm
Summary
This is an analysis of the BIOGEN INC. earnings press release filed on 2026-04-06. Due to the limited information in the provided text, a comprehensive summary is not possible. The press release contains forward-looking statements and discusses financial results, but lacks specific figures.
Key Highlights
- 1
Revenue: $X.XB (up/down X% YoY) - Data not available in provided text
- 2
Net Income: $X.XB (up/down X% YoY) - Data not available in provided text
- 3
EPS: $X.XX vs $X.XX estimated - Data not available in provided text
- 4
Significant acquired in-process research and development, upfront and milestone expense expected to impact GAAP and non-GAAP net income
Informational and educational content only. Not investment advice.